When do we monitor for the effects of a "therapeutic" myocardial infarction?
Thompson
Christine
C
University of California San Francisco Medical Center, San Francisco, CA 94341-0210, USA.
Tsiperfal
Angela
A
D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D004562:Electrocardiography; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000503:physiopathology
D000431:Ethanol